Advanced search
Publication Cover
Pathogens and Global Health Volume 112, 2018 - Issue 4
Submit an article Journal homepage
91
Views
1
CrossRef citations to date
0
Altmetric
Short Communication

Assessment of Baseline Antibodies to Pandemic Influenza A/H1N1/2009 Virus in Ogbomoso, Oyo State, Nigeria

E. K. OladipoDepartment of Pure and Applied Biology (Microbiology Unit), Ladoke Akintola University of Technology, Ogbomoso, Nigeria;Virus Research Laboratory, Department of Microbiology, Adeleke University, Ede, NigeriaCorrespondence[email protected]
[email protected]
,
E. H. AwoyeluDepartment of Pure and Applied Biology (Microbiology Unit), Ladoke Akintola University of Technology, Ogbomoso, Nigeria
&
J. K. OlokeDepartment of Pure and Applied Biology (Microbiology Unit), Ladoke Akintola University of Technology, Ogbomoso, Nigeria
Pages 227-231 | Published online: 23 Apr 2018

References

  • Ng S, Gordon A. Influenza burden and transmission in the tropics. Curr Epidemol Rep. 2015;2:89–100.10.1007/s40471-015-0038-4
  • Prachayangprecha S, Makkoch J, Payungporn S, et al. Serological analysis of human pandemic influenza (H1N1) in Thailand. J Health Popul Nutr. 2010;28(6):537–544.
  • Cox CM, Goodin K, Fisher E, et al. Prevalence of 2009 Pandemic Influenza A (H1N1) Virus Antibodies, Tampa Bay Florida November–December, 2009. PLoS One. 2011;6(12):e29301.10.1371/journal.pone.0029301
  • Zhu-Nan L, Seh-Ching L, Carney PJ, et al. IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 Hemagglutinin in infected persons during the first wave of the 2009 Pandemic in the United States. Clin Vacc Immunol. 2014;21(8):1054–1060.
  • Truelove S, Zhu H, Lessler J, et al. A comparison of hemagglutination inhibition and neutralization assays for characterizing immunity to seasonal influenza A. Influenza Other Respiratory Viruses. 2016;10:518–524. doi:10.1111/irv.12408.
  • Centers for Disease Control and Prevention. Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010–11 seasonal influenza vaccine on cross-reactive antibodies – United States. Atlanta, GA: Centers for Disease Control and Prevention; 2012.
  • Hobson D, Curry RL, Beare AS, et al. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond). 1972;70:767–777.10.1017/S0022172400022610
  • De Jong JC, Palache AM, Beyer WEP, et al. Haemagglutination-inhibiting antibody to influenza virus. Dev Biol. 2003;115:63–73.
  • Bauman R. Chapter 17. Immunization and immune testing. In: Microbiology with diseases by body system. 4th ed. New York (NY): Benjamin-Cummings; 2008. p.  550–750.
  • Ntshoe GM, McAnerney JM, Tempia S, et al. Influenza epidemiology and vaccine effectiveness among patients with influenza-like illness, viral watch sentinel sites, South Africa, 2005–2009. PLoS One. 2014;9(4):e94681.10.1371/journal.pone.0094681
  • Labato MI, Contrini MM, Lazzarini D, et al. Pandemic influenza A/H1N1 2009 antibodies in the metropolitan area of Buenos Aires in Argentina. Intl J Infect Dis. 2014;19:20–25.10.1016/j.ijid.2013.09.021
  • Dudareva S, Schweiger B, Thamm M, et al. Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in german adult population in pre- and post-pandemic period. PLoS One. 2011;6(6):e21340.10.1371/journal.pone.0021340
  • Bandaranayake D, Huang QS, Bissielo A, et al. Risk factors and immunity in a nationally representative population following the 2009 influenza A (H1N1) pandemic. PLoS One. 2010;5:e13211.10.1371/journal.pone.0013211
  • Buda S, Kopke K, Haas W. Epidemiological characteristics of the influenza pandemic (H1N1) 2009 in Germany based on the mandatory notification of cases. BundesgesundheitsblattGesundheitsforschung Gesundheitsschutz. 2010;53:1223–1230.10.1007/s00103-010-1158-0
  • Miller E, Hoschler K, Hardelid P, et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross sectional serological study. Lancet. 2010;375:1100–1108.10.1016/S0140-6736(09)62126-7
  • Chen MI, Lee VJ, Lim WY, et al. 2009 Influenza A (H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA. 2010;303:1383–1391.10.1001/jama.2010.404
  • Tian LL, Shi WX, Ying D, et al. Serologic survey of pandemic influenza A (H1N1 2009) in Beijing, China. Prev Med. 2010;52:71–74.
  • Zimmer SM, Crevar CJ, Carter DM, et al. Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS One. 2010;5:e11601.10.1371/journal.pone.0011601
  • Skowronski DM, Hottes TS, Janjua NZ, et al. Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ. 2010;182:1851–1856.10.1503/cmaj.100910
  • Xu C, Bai T, Iuliano AD, et al. The seroprevalence of pandemic influenza H1N1 (2009) virus in China. PLoS One. 2011;2011(6):e17919.10.1371/journal.pone.0017919
  • Hardelid P, Andrews NJ, Hoschler K, et al. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assessment. 2010;14(55):115–192.
  • Reed C, Katz JM, Hancock K, et al. Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the United States following the 2009 Pandemic. PLoS One. 2012;7(10):e48187. doi:10.1371/journal.pone.0048187.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.